In brief, proteolytic APOE4 fragments may cause Tau protein phosphorylation, neurofibrillary tangles, cytoskeletal changes, and impairment of mitochondrial function, which may explain why APOE4 has a higher risk of AD pathogenicity than APOE3. This evidence concerns the gene MAPT and Alzheimer disease.